Melanoma lymph node metastases - moving beyond quantity in clinical trial design and contemporary practice.

Rhodin, Kristen E; Fimbres, Denisse Porras; Burner, Danielle N; Hollander, Shayna; O'Connor, Margaret H; Beasley, Georgia M

Rhodin, Kristen E; Fimbres, Denisse Porras; Burner, Danielle N; Hollander, Shayna; O'Connor, Margaret H; Beasley, Georgia M.

Afiliación

Rhodin KE; Department of Surgery, Duke University Medical Center, Durham, NC, United States.
Fimbres DP; Duke University School of Medicine, Durham, NC, United States.
Burner DN; Duke University School of Medicine, Durham, NC, United States.
Hollander S; Department of Surgery, Duke University Medical Center, Durham, NC, United States.
O'Connor MH; Department of Surgery, Duke University Medical Center, Durham, NC, United States.
Beasley GM; Department of Surgery, Duke University Medical Center, Durham, NC, United States.

Front Oncol ; 12: 1021057, 2022.

Article en En | MEDLINE | ID: mdl-36411863

Palabras clave

clinical trials; immunotherapy; lymph nodes; melanoma; metastasis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google